
Developer of Functional Membrane for Biological Tissues and Derived Medical Devices
Background
Background
Recently,Daotong Family Enterprise——Bochuang BiotechThe "Ophthalmic Biomaterials Joint Laboratory," co-built with the Engineering Research Center of Medical Biomedical Materials, Ministry of Education, East China University of Science and Technology, was officially inaugurated in the new building of the School of Materials Science and Engineering at East China University of Science and Technology.The laboratory will focus on cutting-edge research, product development, and technological innovation in ophthalmic biomaterials, promoting scientific and technological progress and industrial development in the field of ophthalmic biomaterials, enhancing the core competitiveness of both parties in this field, and achieving mutual benefit and win-win results.
The unveiling ceremony was hosted by Professor Xue Qu, doctoral supervisor of East China University of Science and Technology and winner of the National Outstanding Youth Fund. Professor Yuanyuan Yuan, Party Secretary of the School of Materials Science and Engineering of East China University of Science and Technology, and Dr. Haoqi Tan, General Manager of Bochuang Biotech, signed the cooperation agreement for the joint laboratory. The signing was witnessed by Academician Changsheng Liu, Director of the Engineering Research Center of Medical Biomedical Materials, Ministry of Education, East China University of Science and Technology, and Professor Xue Qu. After the two parties formally signed the cooperation agreement, Academician Changsheng Liu and Dr. Haoqi Tan, General Manager of Bochuang Biotech, jointly unveiled the joint laboratory.
Swipe left to view more
The unveiling and establishment of this joint laboratory not only deepens the cooperative relationship but also ignites a passionate collision of innovative sparks!Academician Changsheng Liu pointed out in his speech: "The establishment of the joint laboratory will focus on three principles: 'demand-oriented, collaborative innovation, and industry leadership,' with an emphasis on breaking through key technological bottlenecks in ophthalmic biomaterials. He emphasized that the laboratory needs to break away from traditional research models and establish a flexible mechanism for transforming achievements, promoting the transition of technology from the lab to clinical applications."Achieving innovative breakthroughs from 0 to 1 for the service of health, aligning with international standards, and transforming 1 into 10 and then into 100 is precisely where the value of research lies. This process is akin to a hen hatching eggs, gradually incubating multiple technologies, establishing related enterprises, and then forming close ties with schools to create a complete innovation chain. From original innovation, integrated innovation to application technology innovation, our industry status will undoubtedly rise further. I sincerely congratulate the establishment of the Ophthalmic Biomaterials Joint Laboratory between East China University of Science and Technology and Bochuang Biotech—a moment that will go down in history. I believe that this model will continue to grow and thrive in the future.
Dr. Tan Haoqi stated: "The establishment of the joint laboratory is an important milestone in Bochuang Biotech's 'innovation-driven development' strategy. The company will rely on the scientific research strength of the Engineering Research Center for Medical Biomaterials of East China University of Science and Technology to accelerate the research and development, iteration, and upgrading of products in the direction of ophthalmic biomaterials.""I am extremely grateful to my alma mater for nurturing me, and deeply thankful to the academician team for their technical and talent support to Bochuang Biotech. I feel honored to maintain close connections and cooperation with the school after graduation, and will continue to contribute my part to the university and society."
The collaboration between East China University of Science and Technology and Bochuang Biotech represents the deep integration of "academic think tanks" with "industrial engines" and the precise alignment of "innovation chains" with "industrial chains." With the joint efforts of both parties, it is believed that the joint laboratory will become an innovation hub in the field of ophthalmic biomaterials, contributing wisdom and strength to the construction of a Healthy China!
END
ID:daltonventure
Long press to follow
R E C O M M E N D E D R E A D I N G